Find Grants for School Districts

Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.

 

Total Dollars Available
$ 100 Trillion

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Deadline: May 25, 2027


Opportunity Number: PAR-28-057

Agency: National Institutes of Health

Open Date: September 25, 2026

Close Date: May 25, 2027

Status: Posted

CFDA Numbers: 93.393

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Deadline: November 5, 2029


Opportunity Number: PAR-28-056

Agency: National Institutes of Health

Open Date: September 25, 2026

Close Date: November 5, 2029

Status: Posted

CFDA Numbers: 93.393

Deployed Warfighter Protection FY27

Deadline: March 17, 2027


Opportunity Number: AFPMB-BAA-27-01

Agency: ACC-APG-Detrick

Open Date: September 24, 2026

Close Date: March 17, 2027

Status: Posted

CFDA Numbers: 12.355

Advancing Global Health

Deadline: February 14, 2027


Opportunity Number: DFOP0017890

Agency: Bureau of Global Health Security and Diplomacy

Open Date: September 21, 2026

Close Date: February 14, 2027

Status: Posted

CFDA Numbers: 19.029

BJA FY 2026 Students, Teachers, and Officers Preventing (STOP) School Violence Program

Deadline: October 30, 2026


Opportunity Number: O-BJA-2026-172709

Agency: Bureau of Justice Assistance

Open Date: September 21, 2026

Close Date: October 30, 2026

Status: Posted

CFDA Numbers: 16.839

OJJDP FY 2026 Multistate Mentoring Programs

Deadline: October 29, 2026


Opportunity Number: O-OJJDP-2026-172745

Agency: Office of Juvenile Justice Delinquency Prevention

Open Date: September 21, 2026

Close Date: October 29, 2026

Status: Posted

CFDA Numbers: 16.726

Impact Aid Discretionary Construction Grant Program - 84.041C

Deadline: November 10, 2026


Opportunity Number: DOL-OESE-34832

Agency: Office of Elementary and Secondary Education

Open Date: September 8, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 84.041

Accelerating Scale-up and Pre-piloting of Emerging Chemical Technologies (ASPECT)

Deadline: December 1, 2026


Opportunity Number: DE-FOA-0003647

Agency: Golden Field Office

Open Date: September 4, 2026

Close Date: December 1, 2026

Status: Posted

CFDA Numbers: 81.087

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Deadline: November 18, 2026


Opportunity Number: HT942526BCRPBTA122

Agency: Defense Health Agency Contracting Activity - DHACA

Open Date: September 3, 2026

Close Date: November 18, 2026

Status: Posted

CFDA Numbers: 12.420

DoW Breast Cancer, Clinical Research Extension Award

Deadline: November 18, 2026


Opportunity Number: HT942526BCRPCREA2

Agency: Defense Health Agency Contracting Activity - DHACA

Open Date: September 3, 2026

Close Date: November 18, 2026

Status: Posted

CFDA Numbers: 12.420

Request for Information - Gauging Investor Interest in the Development and Commercialization of Subsurface Energy Technologies

Deadline: November 5, 2026


Opportunity Number: DE-FOA-0003671

Agency: National Energy Technology Laboratory

Open Date: September 3, 2026

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 81.089

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Deadline: November 10, 2026


Opportunity Number: RFA-AI-27-005

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.855

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

Deadline: November 10, 2026


Opportunity Number: RFA-AG-27-010

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.866

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Deadline: October 9, 2028


Opportunity Number: RFA-AI-27-014

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: October 9, 2028

Status: Posted

CFDA Numbers: 93.839, 93.837, 93.853, 93.840, 93.846, 93.867, 93.855, 93.233, 93.279, 93.838

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)

Deadline: July 16, 2028


Opportunity Number: PAR-27-096

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: July 16, 2028

Status: Posted

CFDA Numbers: 93.361, 93.121, 93.307, 93.866

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Deadline: November 10, 2026


Opportunity Number: RFA-AI-27-002

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.855

NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)

Deadline: April 17, 2029


Opportunity Number: PAR-27-051

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: April 17, 2029

Status: Posted

CFDA Numbers: 93.853, 93.279, 93.121, 93.242, 93.273, 93.399

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)

Deadline: June 12, 2028


Opportunity Number: PAR-27-112

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: June 12, 2028

Status: Posted

CFDA Numbers: 93.866

Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)

Deadline: May 25, 2028


Opportunity Number: PAR-27-127

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: May 25, 2028

Status: Posted

CFDA Numbers: 93.242

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Deadline: June 23, 2028


Opportunity Number: RFA-NS-27-002

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: June 23, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.853, 93.867, 93.286, 93.372, 93.866, 93.865, 93.173, 93.213, 93.273

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Deadline: January 25, 2027


Opportunity Number: PAR-28-062

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: January 25, 2027

Status: Posted

CFDA Numbers: 93.399

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Deadline: June 16, 2028


Opportunity Number: PAR-27-053

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: June 16, 2028

Status: Posted

CFDA Numbers: 93.279

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Deadline: January 11, 2027


Opportunity Number: RFA-CA-27-005

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: January 11, 2027

Status: Posted

CFDA Numbers: 93.394, 93.395

Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)

Deadline: July 7, 2028


Opportunity Number: PAR-27-076

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: July 7, 2028

Status: Posted

CFDA Numbers: 93.855, 93.233, 93.838, 93.840, 93.879, 93.307, 93.839, 93.273, 93.372, 93.853, 93.310, 93.113, 93.173, 93.398, 93.847, 93.865, 93.242, 93.866, 93.121, 93.213, 93.837

Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)

Deadline: October 2, 2028


Opportunity Number: PAR-27-068

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: October 2, 2028

Status: Posted

CFDA Numbers: 93.859

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.